Potential Use of Cyclodextrins for the Improvement of Ocular Bioavailability of Meloxicam

Journal Title: IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) - Year 2017, Vol 12, Issue 5

Abstract

Meloxicam (MX) is a nonsteroidal anti-inflammatory drug. Also, it is a more distinct COX-2 inhibitor than diclofenac with less secondary effects. Yet, its usage for the treatment of ophthalmic inflammations has retarded due to its low aqueous solubility and dissolution rate. The aim of this study was to prepare the inclusion complexes of MX with cyclodextrins to enhance its aqueous solubility, dissolution rate, and ocular bioavailability. Formulation of those complexes into different ocular delivery systems and also in-vitro and invivo assessments has not been accomplished in the earlier attempts. In this study, MX was complexed with each of hydroxyl propyl-β-cyclodextrin (HP-β-CyD) and β-cyclodextrin (β-CyD) utilizing kneading, co-evaporation, and freeze drying techniques. Moreover, the prepared complexes were discriminated in the solid state by Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD). These complexes were incorporated into eye drops, eye gels, and ocuserts using hydroxypropyl methylcellulose (HPMC), sodium carboxy methylcellulose (Sod. CMC), carbopol 940 (CP940), and sodium alginate (Sod. ALG). These formulae were characterized on the subject of drug content, pH, viscosity, in-vitro release characteristics. Kinetic analysis of the release data was done. Real inclusion complexes were obtained with co-evaporation method that confirmed by DSC investigations. The MX release was enhanced by complexation especially with HP-β-CyD. Ocular bioavailability of meloxicam from the selected formulations was investigated. In-vivo study proved that, ocuserts containing MX-HP-CyD complexes showed pronounced ocular bioavailability than MX alone which indicated by higher AUC, Cmax and relative bioavailability values.

Authors and Affiliations

Abd-Elgawad H. Abd-Elgawad, Osama A. Soliman, Marwa S. El-Dahan,, Ghada A. A. El-Emam*

Keywords

Related Articles

Analysis of Pralatrexate Using Simple and Fast Reverse Phase High Performance Liquid Chromatographic Method

A simple, specific, precise, accurate, and sensitive Reverse Phase High Performance Liquid Chromatographic method has been developed for the determination of Pralatrexate in both pure and pharmaceutical dosage forms. In...

Anti-Diabetic Effect of Occimum Gratissimum on Blood Glucose Level in Alloxan Induced Diabetic Rats

In The Present Study, The Anti Diabetic Effect Of Occimum Gratissimum On Alloxan Induced Diabetic Rats Was Investigated Using Standard Methods. The Result Revealed That The Blood Glucose Levels Of The Rats Were Reduced F...

Protease Production from Immobilized Bacillus Subtilis and Its Application

Biofilm is a complex aggregation of microorganisms growing on a solid substrate. Biofilms are characterized by structural heterogeneity, genetic diversity, complex community interactions, and an extracellular matrix of p...

Antioxidant properties of Canarium schweinfurthii, (including its quality indices), and Elaeis guineensis oils on rats exposed to paraquat-induced lipid peroxidation

The antioxidant property of Canarium schweinfurthii (C.s) oil in comparison with palm oil was studied in albino Wistar rats pretreated orally with the oils for 16 consecutive days. Thereafter, 20 and 80mg/kg body weight...

Studies On Growth And Survival Rate Of Pearl Freshwater Mussel Lamellidens Marginalis During The Culture In A Pond

The culture of Pearl Freshwater Mussel in a pond have been studied for a period of one year (from July 2014 to June 2015) with the data on growth and survival factors and discussed with reference to similar work. During...

Download PDF file
  • EP ID EP390925
  • DOI 10.9790/3008-1205017996
  • Views 100
  • Downloads 0

How To Cite

Abd-Elgawad H. Abd-Elgawad, Osama A. Soliman, Marwa S. El-Dahan, , Ghada A. A. El-Emam* (2017). Potential Use of Cyclodextrins for the Improvement of Ocular Bioavailability of Meloxicam. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS), 12(5), 79-96. https://europub.co.uk./articles/-A-390925